Kuros Biosciences Trading Update
- Closing price: The share of Kuros Biosciences (KURN.SW) closed at CHF 19.70 on Thursday, 22 October 2026, after rising 3.79 % during the 24‑hour period ending at 11:00 AM Central Europe.
- Trading volume: In the last 24 hours, approximately CHF 7.9 million worth of shares were traded.
- Market capitalization: The company’s market cap is CHF 764.9 million.
- Shares outstanding: About 39.8 million shares are currently in circulation.
- Price performance:
- 52‑week high: CHF 32.48 (recorded 28 November 2025).
- 52‑week low: CHF 16.46 (recorded 18 September 2026).
- 200‑day simple moving average: CHF 21.97.
- Month‑to‑month change: +10.45 % since the previous month‑end.
Recent Performance of Related Stocks
| Company | Recent 24‑hour change | Current price | Market cap |
|---|---|---|---|
| Moonlake Immunotherapeutics (MLTX) | +3.2 % | USD 10.65 | USD 878.3 million |
| Autoneum (AUTN.SW) | –0.65 % | CHF 122.8 | CHF 714 million |
| Docmorris (DOCM.SW) | +1.71 % | CHF 15.71 | CHF 819.8 million |
| Infracore (INFRAC.SW) | +1.77 % | CHF 51.8 | CHF 778.6 million |
| Aebi Schmidt (AEBI) | +0.72 % | USD 11.23 | USD 865.3 million |
Autoneum’s price‑to‑earnings ratio is 11.64.
Company Profile
Kuros Biosciences AG is a Swiss‑based company headquartered in Schlieren. The firm specializes in orthobiologics, developing products for tissue repair and regeneration, primarily targeting the treatment of bony defects and stimulation of bone formation. Operations are conducted in both the United States and Europe. Kuros Biosciences is listed on the SIX Swiss Exchange. For additional details, visit the company’s website at www.kuros.ch .
